Home
News & Analysis

News & Analysis

Neglect begets opportunity in femtech IP

Femtech entrepreneurs can take advantage of large empty spaces on the patent landscape to secure IP protection for their innovations

The challenges that trade secrets pose to IP stakeholders

For companies, policy makers and service providers, the growing importance of know-how as a quantifiable asset presents dangers and opportunities

New US trade secrets law a ‘potential sledgehammer’ in dispute negotiations

President can now pick out foreign entities and subject them to a series of sanctions

Latest content

Report finds ‘privateers’ charging royalties 15 times that of major SEP holders

Stout’s research identifies Panasonic, Nokia and Ericsson as the biggest sellers to privateers in the past decade

01 February 2023

InterDigital scores further Lenovo victory, while in-house lawyer avoids embargo breach reprimand

It has been another eventful week as parties await the English High Court’s global FRAND rate decision

01 February 2023

Apple acquisitions are fuelling the growth of its semiconductor patent portfolio

With its long history of patent acquisition, Apple shows no signs of slowing down in its quest to expand its position in the semiconductor patent landscape, argues co-authors George Park and David Wright of IPValue in this co-published piece

31 January 2023

US judge’s pursuit of ownership disclosure triggers IP Edge filing shift from Delaware

NPEs connected with the patent assertion entity have moved cases south to Texas

31 January 2023

English High Court backs Oxford University in landmark tech transfer IP ruling

OUI’s patent policies were not unfair to spinout co-founder under consumer protection laws

31 January 2023

The busiest US patent firms in the most-litigated tech area of 2022

Docket Navigator data shows Rabicoff Law has most patentee cases while Fish & Richardson leads for patent challengers in the litigious computers, communication and e-commerce technology centre

30 January 2023

Ten things to know about the controversial Humira patent saga

With Amgen’s biosimilar finally set to launch in the US, IAM looks back on arguably the most interesting set of pharma patent disputes in recent years

30 January 2023

Nokia inks Samsung deal; Ericsson set for 5G licensing push; ERS Genomics willing to litigate CRISPR patents; AI data mining subject of new lawsuits; trade secrets moving to centre stage; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days

29 January 2023

The FTC’s war against US technology competition with China

Saturday Opinion: Supporting the legality of fair non-compete agreements will enhance foreign investors’ reasonable expectations of protection by the US IP system

28 January 2023

Apple victory overturning $308.5M verdict is a torpedo for ‘submarine patents’

CAFC ruling against Personalized Media Communications raises risks when enforcing rights obtained before entry of General Agreement on Tariffs and Trade

27 January 2023

Unlock unlimited access to all IAM content